{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Bensalem",
      "state": "PA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA200295"
        ],
        "brand_name": [
          "LIOTHYRONINE SODIUM"
        ],
        "generic_name": [
          "LIOTHYRONINE SODIUM"
        ],
        "manufacturer_name": [
          "SIGMAPHARM LABORATORIES, LLC"
        ],
        "product_ndc": [
          "42794-018",
          "42794-019",
          "42794-020"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "LIOTHYRONINE SODIUM"
        ],
        "rxcui": [
          "903456",
          "903697",
          "903703"
        ],
        "spl_id": [
          "f1f181e3-ceed-1d17-e053-2995a90af5cd"
        ],
        "spl_set_id": [
          "38ef3766-bb9a-402e-9e4a-ad8bb5b26e4c"
        ],
        "package_ndc": [
          "42794-018-02",
          "42794-018-12",
          "42794-018-06",
          "42794-019-02",
          "42794-019-06",
          "42794-019-12",
          "42794-020-02",
          "42794-020-12"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0342794018121",
          "0342794019128",
          "0342794020124"
        ],
        "unii": [
          "GCA9VV7D2N"
        ]
      },
      "product_type": "Drugs",
      "event_id": "68123",
      "recalling_firm": "SigmaPharm Laboratories LLC",
      "address_1": "3375 Progress Dr",
      "address_2": "N/A",
      "postal_code": "19020-5801",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide and Puerto Rico",
      "recall_number": "D-1344-2014",
      "product_description": "Liothyronine Sodium Tablets, USP 5 mcg, Rx Only, a) 100-count bottle NDC 42794-018-02 and b) 1000-count bottle NDC 42794-018-06, SigmaPharm Laboratories, LLC, Bensalem, Pa.",
      "product_quantity": "43,007 Bottles",
      "reason_for_recall": "Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a potential carryover of trace amounts of a previously manufactured product.",
      "recall_initiation_date": "20140422",
      "center_classification_date": "20140521",
      "termination_date": "20150316",
      "report_date": "20140528",
      "code_info": "Lot #s: a) 1302201, Exp 01/2015; 1305501, Exp 03/2015; 1314801, Exp 10/2015; b) 1302202, Exp 01/2015"
    }
  ]
}